We demonstrated that SYK is critically involved in the acquisition of a DAM/MGnD phenotype in neurodegenerative disease and that disruption of this key signalling hub in microglia causes pronounced deficits in microglial activation, including defective Aβ phagocytosis and stunted proliferation in response to AD‐associated neuropathology. Here, SYK is linked to neurodegenerative disease.